Pharmacotherapy
A Pathophysiologic Approach
(Sprache: Englisch)
Pharmacotherapy: A Pathophysiological Approach uses evidence-based approaches to the drug treatment of diseases. It is the most widely-used and comprehensive pharmacotherapy textbook/reference avaialable for pharmacists and prescribers. Now in a new full-color format.
Leider schon ausverkauft
versandkostenfrei
Buch
67.60 €
Produktdetails
Produktinformationen zu „Pharmacotherapy “
Pharmacotherapy: A Pathophysiological Approach uses evidence-based approaches to the drug treatment of diseases. It is the most widely-used and comprehensive pharmacotherapy textbook/reference avaialable for pharmacists and prescribers. Now in a new full-color format.
Klappentext zu „Pharmacotherapy “
The benchmark evidence-based pharmacotherapy text-now in full color! When it comes to helping you develop a mastery of evidence-based medicine for optimal patient outcomes, no book can match Pharmacotherapy: A Pathophysiologic Approach . Like the discipline it covers, the scope of this trusted resource goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs. The book also delves into psychosocial issues that affect compliance topics related to a patient's ability to understand and manage often-complex therapy and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes. Pharmacotherapy delivers everything you need to provide safe, efficacious drug therapy across the full range of therapeutic categories. FEATURES NEW! Expanded evidence-based recommendations NEW! Extended coverage of the timely issue of palliative care and pain medicine NEW! Important chapters on Pulmonary Hypertension, Disorders of Calcium and Phosphorus Homeostasis, and Multiple Myeloma, Outstanding pedagogy, including: Key Concepts highlighted in each chapter Clinical Presentation boxes summarize the most common disease signs and symptoms covered in each chapter Clinical Controversies boxes-presented in the Treatment sections of the disease-oriented chapters-examine the complicated issues faced by students and clinicians in providing drug therapy Clear therapeutic recommendations in each disease-specific chapter Evaluation of Therapeutic Outcomes boxes in each disease-specific chapter, containing key monitoring guidelines that facilitate the development of a pharmaceutical, nursing, or medical care plan
Inhaltsverzeichnis zu „Pharmacotherapy “
Section 1: Foundation Issues Section Editor: L. Michael Posey1. Pharmacoeconomics: Principles, Methods, and Applications (Web-only)Lisa A. Sanchez
2. Health Outcomes and Quality of Life (Web-only) Stephen Joel Coons
3. Health Literacy and Medication Use (Web-only) Irakua V, Bazaldua and Sunil Kripalani
4. Documentation of Pharmacy Services (Web-only) George E. MacKinnon, III and Neil J. MacKinnon
5. Clinical Pharmacokinetics and Pharmacodynamics Larry A. Bauer
6. Pharmacogenetics Larisa H. Cavallari and Y. W. Francis Lam
7. Pediatrics Milap C. Nahata and Carol Taketomo
8. Geriatrics Catherine I. Starner, Shelly L. Gray, David R. P. Guay, Emily R. Hajjar, Steven M. Handler, and Joseph T. Hanlon
9. PharmacoepidemiologyAndy Stergachis, Thomas K. Hazlet, and Denise Boudreau
10. Clinical ToxicologyPeter A. Chyka
11. Emergency Preparedness: Identification and Management of Biological Exposures (Web-only) Colleen M. Terriff, Jason E. Brouillard, Lisa T. Costanigro, and Jessica S. Gruber
12. Emergency Preparedness: Identification and Management of Chemical and Radiological Exposures (Web-only) Greene Shepherd and Richard B. Schwartz
Section 2: Cardiovascular Disorders Section Editor: Robert L. Talbert
13. Cardiovascular Testing Robert Chilton and Robert L. Talbert
14. Cardiopulmonary ResuscitationJeffrey F. Barletta and Jeffrey L. Wilt
15. Hypertension Joseph J. Saseen and Eric J. MacLaughlin
16. Heart Failure Robert B. Parker, Jo E. Rodgers, and Larisa H. Cavallari
17. Ischemic Heart Disease Robert L. Talbert
18. Acute Coronary SyndromesSarah A. Spinler and Simon de Denus
19. The Arrhythmias Cynthia A. Sanoski, Marieke Dekker Schoen, and Jerry L. Bauman
20. Diastolic Heart Failure and the Cardiomyopathies
21. Venous Thromboembolism Stuart T. Haines, Daniel M. Witt, and Edith A.
... mehr
Nutescu
22. StrokeSusan C. Fagan, David C. Hess
23. Hyperlipidemia Robert L. Talbert
24. Peripheral Arterial Disease Barbara J. Hoeben and Robert L. Talbert
25. Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock Robert MacLaren, Maria I. Rudis, and Joseph F. Dasta
26. Hypovolemic ShockBrian L. Erstad
Section 3: Respiratory Disorders Section Editor: Robert L. Talbert
27. Introduction to Pulmonary Function Testing Jay I. Peters and Stephanie M. Levine
28. AsthmaH. William Kelly and Christine A. Sorkness
29. Chronic Obstructive Pulmonary Disease Dennis M. Williams and Sharya V. Bourdet
30. Pulmonary Hypertension Robert Talbert, Rebecca Boudreaux, Rebecca Owens
31. Drug-Induced Pulmonary Diseases Hengameh H. Raissy, Michelle Harkins, and Patricia L. Marshik
32. Cystic Fibrosis Gary Milavetz
Section 4: Gastrointestinal Disorders Section Editor: Joseph T. DiPiro
33. Evaluation of the Gastrointestinal Tract Keith M. Olsen, Marie A. Chisholm, and Mark W. Jackson
34. Gastroesophageal Reflux DiseaseDianne B. Williams and Robert R. Schade
35. Peptic Ulcer DiseaseRosemary R. Berardi and Lynda S. Welage
36. Inflammatory Bowel Disease Brian A. Hemstreet and Joseph T. DiPiro
37. Nausea and VomitingCecily V. DiPiro
38. Diarrhea, Constipation, and Irritable Bowel Syndrome William J. Spruill and William E. Wade
39. Portal Hypertension and CirrhosisJulie Sease Altman, Edward G. Timm, and James J. Stragand
40. Drug-Induced Liver DiseaseWilliam R. Kirchain and Rondall E. Allen
41. PancreatitisRosemary R. Berardi and Patricia A. Montgomery
42. Viral HepatitisPaulina Deming, Renee-Claude Mercier, and Manjunath P. Pai
43. Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity Y. W. Francis Lam
Section 5: Renal Disorders Section Editor: Gary R. Matzke
44 Quantification of Renal Function Thomas C. Dowling
45 Acute Renal Failure William Dager and Anne Spencer
46 Chronic Kidney Disease: Progression-Modifying Therapies Melanie S. Joy, Abhijit Kshirsagar, and Nora Franceschini
47 Chronic Kidney Disease: Management of Complications Joanna Q. Hudson
48 Hemodialysis and Peritoneal Dialysis (Web-only) Edward F. Foote and Harold J. Manley
49 Drug-Induced Kidney Disease Thomas D. Nolin and Jonathan Himmelfarb
50 Glomerulonephritis Alan H. Lau
51 Drug Therapy Individualization for Patients with Renal Insufficiency Gary R. Matzke and Reginald F. Frye
52 Disorders of Sodium and Water HomeostasisJames D. Coyle, Melanie S. Joy, and Gerald A. Hladik
53 Disorders of Calcium and Phosphorus Homeostasis Amy Barton Pai and Mark Rohrschieb
54 Disorders of Potassium and Magnesium Homeostasis Donald F. Brophy and Todd W. B. Gehr
55 Acid-Base Disorders Gary R. Matzke, John W. Devlin, and Paul M. Palevsky
Section 6: Neurologic Disorders Section Editor: Barbara G. Wells
56 Evaluation of Neurologic IllnessSusan C. Fagan and Fenwick T. Nichols
57 Multiple Sclerosis Jacquelyn L. Bainbridge and John R. Corboy
58 Epilepsy Susan J. Rogers and Jose E. Cavazos
59 Status Epilepticus Stephanie J. Phelps, Collin A. Hovinga, and James W. Wheless
60 Acute Management of the Brain Injury Patient Bradley A. Boucher and Shelly D. Timmons
61 Parkinson's Disease Jack J. Chen, Merlin V. Nelson, and David M. Swope
62 Pain Management and Palliative Care Terry J. Baumann and Jennifer Strickland
63 Headache Disorders Deborah S. Minor and Marion R. Wofford
Section 7: Psychiatric Disorders Section Editor: Barbara G. Wells
64 Evaluation of Psychiatric IllnessPatricia A. Marken, Mark E. Schneiderhan, and Stuart Munro
65 Childhood Disorders Julie Ann Dopheide, Jane Tran Tesoro, and Michael Malkin
66 Eating Disorders Steven C. Stoner
67 Alzheimer's Disease Patricia W. Slattum, Russell H. Swerdlow, and Angela Massey Hill
68 Substance-Related Disorders: Overview and Depressants, Stimulants, and Hallucinogens Paul L. Doering and Lisa A. Boothby
69 Substance-Related Disorders: Alcohol, Nicotine, and Caffeine Paul L. Doering, W. Klugh Kennedy, and Lisa A. Boothby
70 Schizophrenia M. Lynn Crismon, Tami R. Argo, and Peter F. Buckley
71 Depressive Disorders Christian J. Teter, Judith C. Kando, Barbara G. Wells, and Peggy E. Hayes
72 Bipolar Disorder Shannon J. Drayton and Benjamin Weinstein
73 Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders Cynthia K. Kirkwood, Sarah T. Melton
74 Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder Cynthia K. Kirkwood, Eugene H. Makela, and Barbara G. Wells
75 Sleep Disorders John M. Dopp and Bradley G. Phillips
22. StrokeSusan C. Fagan, David C. Hess
23. Hyperlipidemia Robert L. Talbert
24. Peripheral Arterial Disease Barbara J. Hoeben and Robert L. Talbert
25. Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock Robert MacLaren, Maria I. Rudis, and Joseph F. Dasta
26. Hypovolemic ShockBrian L. Erstad
Section 3: Respiratory Disorders Section Editor: Robert L. Talbert
27. Introduction to Pulmonary Function Testing Jay I. Peters and Stephanie M. Levine
28. AsthmaH. William Kelly and Christine A. Sorkness
29. Chronic Obstructive Pulmonary Disease Dennis M. Williams and Sharya V. Bourdet
30. Pulmonary Hypertension Robert Talbert, Rebecca Boudreaux, Rebecca Owens
31. Drug-Induced Pulmonary Diseases Hengameh H. Raissy, Michelle Harkins, and Patricia L. Marshik
32. Cystic Fibrosis Gary Milavetz
Section 4: Gastrointestinal Disorders Section Editor: Joseph T. DiPiro
33. Evaluation of the Gastrointestinal Tract Keith M. Olsen, Marie A. Chisholm, and Mark W. Jackson
34. Gastroesophageal Reflux DiseaseDianne B. Williams and Robert R. Schade
35. Peptic Ulcer DiseaseRosemary R. Berardi and Lynda S. Welage
36. Inflammatory Bowel Disease Brian A. Hemstreet and Joseph T. DiPiro
37. Nausea and VomitingCecily V. DiPiro
38. Diarrhea, Constipation, and Irritable Bowel Syndrome William J. Spruill and William E. Wade
39. Portal Hypertension and CirrhosisJulie Sease Altman, Edward G. Timm, and James J. Stragand
40. Drug-Induced Liver DiseaseWilliam R. Kirchain and Rondall E. Allen
41. PancreatitisRosemary R. Berardi and Patricia A. Montgomery
42. Viral HepatitisPaulina Deming, Renee-Claude Mercier, and Manjunath P. Pai
43. Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity Y. W. Francis Lam
Section 5: Renal Disorders Section Editor: Gary R. Matzke
44 Quantification of Renal Function Thomas C. Dowling
45 Acute Renal Failure William Dager and Anne Spencer
46 Chronic Kidney Disease: Progression-Modifying Therapies Melanie S. Joy, Abhijit Kshirsagar, and Nora Franceschini
47 Chronic Kidney Disease: Management of Complications Joanna Q. Hudson
48 Hemodialysis and Peritoneal Dialysis (Web-only) Edward F. Foote and Harold J. Manley
49 Drug-Induced Kidney Disease Thomas D. Nolin and Jonathan Himmelfarb
50 Glomerulonephritis Alan H. Lau
51 Drug Therapy Individualization for Patients with Renal Insufficiency Gary R. Matzke and Reginald F. Frye
52 Disorders of Sodium and Water HomeostasisJames D. Coyle, Melanie S. Joy, and Gerald A. Hladik
53 Disorders of Calcium and Phosphorus Homeostasis Amy Barton Pai and Mark Rohrschieb
54 Disorders of Potassium and Magnesium Homeostasis Donald F. Brophy and Todd W. B. Gehr
55 Acid-Base Disorders Gary R. Matzke, John W. Devlin, and Paul M. Palevsky
Section 6: Neurologic Disorders Section Editor: Barbara G. Wells
56 Evaluation of Neurologic IllnessSusan C. Fagan and Fenwick T. Nichols
57 Multiple Sclerosis Jacquelyn L. Bainbridge and John R. Corboy
58 Epilepsy Susan J. Rogers and Jose E. Cavazos
59 Status Epilepticus Stephanie J. Phelps, Collin A. Hovinga, and James W. Wheless
60 Acute Management of the Brain Injury Patient Bradley A. Boucher and Shelly D. Timmons
61 Parkinson's Disease Jack J. Chen, Merlin V. Nelson, and David M. Swope
62 Pain Management and Palliative Care Terry J. Baumann and Jennifer Strickland
63 Headache Disorders Deborah S. Minor and Marion R. Wofford
Section 7: Psychiatric Disorders Section Editor: Barbara G. Wells
64 Evaluation of Psychiatric IllnessPatricia A. Marken, Mark E. Schneiderhan, and Stuart Munro
65 Childhood Disorders Julie Ann Dopheide, Jane Tran Tesoro, and Michael Malkin
66 Eating Disorders Steven C. Stoner
67 Alzheimer's Disease Patricia W. Slattum, Russell H. Swerdlow, and Angela Massey Hill
68 Substance-Related Disorders: Overview and Depressants, Stimulants, and Hallucinogens Paul L. Doering and Lisa A. Boothby
69 Substance-Related Disorders: Alcohol, Nicotine, and Caffeine Paul L. Doering, W. Klugh Kennedy, and Lisa A. Boothby
70 Schizophrenia M. Lynn Crismon, Tami R. Argo, and Peter F. Buckley
71 Depressive Disorders Christian J. Teter, Judith C. Kando, Barbara G. Wells, and Peggy E. Hayes
72 Bipolar Disorder Shannon J. Drayton and Benjamin Weinstein
73 Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders Cynthia K. Kirkwood, Sarah T. Melton
74 Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder Cynthia K. Kirkwood, Eugene H. Makela, and Barbara G. Wells
75 Sleep Disorders John M. Dopp and Bradley G. Phillips
... weniger
Autoren-Porträt von Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey
Author ProfilesJoseph DiPiro, PharmD, FCCP
Executive Dean and Professor,
South Carolina School of Pharmacy
Robert Talbert, PharmD, FCCP, BCPS
Professor
University of Texas, Health Science Center
Gary Yee, PharmD, FCCP
Professor and Associate Dean for Academic Affairs
University of Nebraska, Medical Center
Gary Matzke, PharmD, FCP, FCCP
Professor and Associate Dean for Clinical Research and Public Policy
Virginia Commonwealth University School of Clinical Research and Public Policy
Barbara Wells, PharmD, FASHP, FCCP, BCPP
Dean and Professor, Executive Director of the Research Institute of Phamaceutical Sciences
University of Mississippi School of Pharmacy
L. Michael Posey, BS Pharm
Editorial Director
American Pharmacists Association
Bibliographische Angaben
- Autoren: Joseph T. DiPiro , Robert L. Talbert , Gary C. Yee , Gary R. Matzke , Barbara G. Wells , L. Michael Posey
- 2011, 8th ed., XXXII, 2559 Seiten, mit farbigen Abbildungen, Maße: 22,8 x 28,5 cm, Gebunden, Englisch
- By Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee et al.
- Verlag: McGraw-Hill Professional
- ISBN-10: 0071703543
- ISBN-13: 9780071703543
Sprache:
Englisch
Kommentar zu "Pharmacotherapy"
0 Gebrauchte Artikel zu „Pharmacotherapy“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Pharmacotherapy".
Kommentar verfassen